New and early-stage life science businesses in the North can pitch for a share of a £500,000 funding pot after a new initiative was launched.
The North of England Life Science Accelerator (NELSA) has been unveiled at the fifth annual BioCap Conference held at Alderley Park Conference Centre in Cheshire.
A group that features the Alderley Park life science campus, which is part of the Manchester Science Partnerships, BioCity, Catapult Ventures, Alderley Park Ventures (APV), N8 Research Partnership, and the Northern Health Science Alliance, has set up the scheme.
The accelerator will be anchored at Alderley Park and aims to support life science businesses in the North.
It is anticipated that seed funding will be provided for up to ten early stage commercialisation projects for a maximum of 12 months in order to facilitate businesses in carrying out proof-of-concept research.
Eligible businesses will also be provided with additional support to help them achieve growth, such as workshops, coaching and access to mentors and industry leaders, as well as use of facilities and equipment at Alderley Park.